BRIEF published on 04/25/2025 at 07:05, 9 months 16 days ago BB Biotech Q1 2025: Portfolio Adjustments Amid Volatile Market Market Volatility Investment Portfolio Biotech Sector BB Biotech FDA Approvals
PRESS RELEASE published on 04/25/2025 at 07:00, 9 months 16 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report covering the first three months of 2025 revealing a net loss of CHF 241 mn. More information at report.bbbiotech.ch/Q125 Financial Results Investment Company BB Biotech AG Interim Report Business Activities
PRESS RELEASE published on 04/25/2025 at 07:00, 9 months 16 days ago BB Biotech Q1 2025: Sharpened portfolio focus amid continued market volatility BB Biotech AG reports net loss in Q1 2025 due to market volatility. Portfolio focus on innovative biotech companies above USD 1 bn. Details on exits and regulatory milestones Market Volatility BB Biotech AG Biotech Companies Q1 2025 Portfolio Focus
BRIEF published on 03/19/2025 at 17:50, 10 months 22 days ago Les actionnaires de BB Biotech AG approuvent le dividende et réélisent le conseil d'administration Dividende Stratégie D'investissement Réélection Du Conseil D'administration BB Biotech Assemblée Générale Annuelle 2025
BRIEF published on 03/19/2025 at 17:50, 10 months 22 days ago BB Biotech AG Shareholders Approve Dividend and Re-Elect Board Investment Strategy Dividend Board Re-election BB Biotech AGM 2025
PRESS RELEASE published on 03/19/2025 at 17:45, 10 months 22 days ago Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 1.80 per share Shareholders at BB Biotech AG’s AGM approve dividend of CHF 1.80 per share and all board proposals. Re-elected board members for another term Shareholders Dividend AGM BB Biotech AG Board Proposals
BRIEF published on 02/21/2025 at 07:05, 11 months 18 days ago BB Biotech AG publie son rapport annuel 2024 Bénéfice Net Proposition De Dividende BB Biotech SA Rapport Annuel 2024 Secteur De La Biotechnologie
BRIEF published on 02/21/2025 at 07:05, 11 months 18 days ago BB Biotech AG Releases 2024 Annual Report Dividend Proposal Net Profit BB Biotech AG Biotechnology Sector 2024 Annual Report
BRIEF published on 02/21/2025 at 07:05, 11 months 18 days ago BB Biotech Navigates Biotech Sector's Early Recovery in 2024 Investment Strategy 2024 Financial Performance BB Biotech Regulatory Milestones Biotech Recovery
BRIEF published on 02/21/2025 at 07:05, 11 months 18 days ago BB Biotech navigue dans la reprise précoce du secteur biotechnologique en 2024 Stratégie D'investissement Résultats Financiers 2024 Biotechnologie BB Reprise De La Biotechnologie Étapes Réglementaires Importantes
Published on 02/11/2026 at 06:00, 1 hour 52 minutes ago Tocvan Announces Restart Of Exploration Drilling At The Gran Pilar Project South Block
Published on 02/11/2026 at 03:05, 4 hours 47 minutes ago CANEX Metals Announces Final Take Up of Gold Basin Shares and Expiry of Successful Gold Basin Offer
Published on 02/11/2026 at 01:00, 6 hours 52 minutes ago Kidoz Inc. Appoints John Nolie as Vice President of Sales, North America
Published on 02/10/2026 at 22:50, 9 hours 2 minutes ago Tectonic Metals Announces Financing of up to $40 Million
Published on 02/10/2026 at 22:15, 9 hours 37 minutes ago Earthwise Minerals Completes Private Placement and Makes Changes to the Management Team
Published on 02/11/2026 at 07:30, 22 minutes ago voestalpine AG: voestalpine increases earnings in the first three quarters of BY 2025/26
Published on 02/11/2026 at 07:30, 22 minutes ago DOUGLAS Group delivers solid performance amid challenging market and economic environment
Published on 02/11/2026 at 07:03, 48 minutes ago Growth target for 2025 exceeded: Commerzbank achieves record operating result
Published on 02/11/2026 at 07:00, 52 minutes ago SCHOTT Pharma with positive start to financial year 2026; outlook confirmed
Published on 02/11/2026 at 07:00, 52 minutes ago Growth target for 2025 exceeded: Commerzbank achieves record operating result
Published on 02/10/2026 at 18:24, 13 hours 27 minutes ago Mersen: Number of shares and voting rights as of January 31, 2026
Published on 02/10/2026 at 18:24, 13 hours 27 minutes ago Mersen : nombre d'actions et de droits de vote au 31 janvier 2026
Published on 02/10/2026 at 18:00, 13 hours 52 minutes ago CIS remporte plusieurs contrats stratégiques en Afrique, en Amérique du Sud et en Asie
Published on 02/10/2026 at 18:00, 13 hours 52 minutes ago CIS wins several strategic contracts in Africa, South America and Asia
